American International Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,430,132
Closed -$39.7M 1962
2024
Q1
$39.7M Sell
1,430,132
-4,069
-0.3% -$113K 0.14% 68
2023
Q4
$41.3M Sell
1,434,201
-52,697
-4% -$1.59M 0.17% 58
2023
Q3
$49.3M Sell
1,486,898
-24,596
-2% -$870K 0.32% 41
2023
Q2
$55.4M Buy
1,511,494
+32,157
+2% +$1.25M 0.34% 38
2023
Q1
$60.4M Buy
1,479,337
+7,387
+0.5% +$319K 0.4% 31
2022
Q4
$75.4M Sell
1,471,950
-30,511
-2% -$1.46M 0.53% 23
2022
Q3
$65.7M Sell
1,502,461
-36,976
-2% -$1.8M 0.48% 22
2022
Q2
$80.7M Sell
1,539,437
-43,581
-3% -$2.22M 0.55% 19
2022
Q1
$82M Sell
1,583,018
-45,095
-3% -$2.34M 0.45% 25
2021
Q4
$96.1M Buy
1,628,113
+16,271
+1% +$806K 0.48% 23
2021
Q3
$69.3M Sell
1,611,842
-97,872
-6% -$4.34M 0.37% 36
2021
Q2
$67K Sell
1,709,714
-23,117
-1% -$899K 0.23% 79
2021
Q1
$62.8K Sell
1,732,831
-52,171
-3% -$1.85M 0.22% 78
2020
Q4
$65.7K Sell
1,785,002
-5,406,471
-75% -$198M 0.24% 68
2020
Q3
$250M Sell
7,191,473
-853,748
-11% -$29.9M 1.2% 8
2020
Q2
$250M Sell
8,045,221
-768,577
-9% -$26.1M 1.2% 10
2020
Q1
$273M Sell
8,813,798
-2,131,251
-19% -$72.6M 1.5% 7
2019
Q4
$407M Buy
10,945,049
+343,713
+3% +$12.2M 1.57% 7
2019
Q3
$361M Sell
10,601,336
-392,103
-4% -$14.3M 1.46% 18
2019
Q2
$452M Sell
10,993,439
-585,933
-5% -$23.3M 1.77% 10
2019
Q1
$467M Sell
11,579,372
-571,927
-5% -$22.9M 1.77% 11
2018
Q4
$503M Sell
12,151,299
-3,421,016
-22% -$142M 2.07% 2
2018
Q3
$651M Sell
15,572,315
-469,270
-3% -$18.1M 2.16% 2
2018
Q2
$552M Sell
16,041,585
-628,094
-4% -$21.5M 1.92% 8
2018
Q1
$561M Sell
16,669,679
-177,014
-1% -$6.09M 1.96% 5
2017
Q4
$579M Buy
16,846,693
+645,148
+4% +$22M 1.9% 13
2017
Q3
$549M Sell
16,201,545
-143,726
-0.9% -$4.62M 1.94% 13
2017
Q2
$521M Buy
16,345,271
+7,431
+0% +$234K 1.86% 16
2017
Q1
$530M Buy
16,337,840
+379,504
+2% +$12M 1.94% 12
2016
Q4
$492M Buy
15,958,336
+1,092,647
+7% +$33.4M 1.9% 12
2016
Q3
$478M Buy
14,865,689
+547,310
+4% +$18.3M 1.9% 17
2016
Q2
$478M Buy
14,318,379
+325,381
+2% +$10.4M 2.01% 12
2016
Q1
$394M Buy
13,992,998
+475,983
+4% +$13.6M 1.54% 19
2015
Q4
$414M Sell
13,517,015
-757,225
-5% -$23.8M 1.7% 8
2015
Q3
$425M Buy
14,274,240
+417,100
+3% +$13.4M 1.86% 2
2015
Q2
$441M Buy
13,857,140
+522,111
+4% +$17M 1.77% 2
2015
Q1
$440M Buy
13,335,029
+413,144
+3% +$13.1M 1.81% 2
2014
Q4
$382M Buy
12,921,885
+1,033,072
+9% +$29.6M 1.65% 5
2014
Q3
$334M Sell
11,888,813
-59,221
-0.5% -$1.66M 1.47% 13
2014
Q2
$336M Buy
11,948,034
+380,283
+3% +$10.8M 1.48% 13
2014
Q1
$353M Buy
11,567,751
+321,458
+3% +$9.58M 1.66% 7
2013
Q4
$327M Buy
11,246,293
+859,440
+8% +$25M 1.57% 7
2013
Q3
$283M Buy
10,386,853
+1,623,064
+19% +$44.2M 1.54% 6
2013
Q2
$227M Buy
+8,763,789
New +$242M 1.36% 7

Other funds holding PFE

American International Group's PFE Position: Q2 2024 in Review

American International Group sold out of Pfizer (PFE) in Q2 2024, closing a stake of 1,430,132 shares — an estimated $39.7M sold.

American International Group first reported a position in PFE in Q2 2013 and held it in 44 quarters. The position peaked at $651M in Q3 2018. 2,873 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

  • American International Group reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 1,430,132 Pfizer shares in Q2 2024, an estimated $39.7M.
  • American International Group first reported a position in Pfizer in Q2 2013 and held it in 44 quarters.
  • American International Group's Pfizer position peaked at $651M in Q3 2018.
  • 2,873 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.